Subject Selection Sample Clauses

Subject Selection a. At the beginning of each quarter, the Chief of Fire may request up to ten employees be randomly generated and provided to the Assistant Chief or the appropriate shift commander. Additionally, the Chief of Fire reserves the right to submit non-random names based upon complaints, information, or allegations received. The submission of non-random names shall remain confidential between the administrative officers b. The shift commander will confidentially choose a day when the employee is scheduled to work that coincides with the availability of a collection official; c. On the date in question, the shift commander will notify the employee’s immediate supervisor of the random drug test and provide the supervisor with an Order to Report form. The immediate supervisor will: i. Notify the employee to respond to headquarters; ii. Sign, date, and indicate the time on the Order to Report form and provide it to the employee; iii. Direct the employee to immediately report to the collection official;

Subject Selection. This study is designed to assess the effect of treatment with VI-0521 on overweight and obese adult subjects with *** or more obesity-related co-morbid conditions either currently uncontrolled or requiring measures beyond first line drug treatment to control. The following eligibility criteria are designed to select subjects for whom protocol treatment is considered appropriate. All relevant medical and non-medical conditions should be taken into consideration when deciding whether this protocol is suitable for a particular subject.

Subject Selection. The study was conducted on patients treated at Virginia Eye Consultants between November 2015 and March 2017. Eligible patients were ≥ 18 years of age who had complete and comprehensive pre-cataract surgery testing, including Lenstar biometry reading. Exclusion criteria for the study included a history of ocular surgical procedures or ocular conditions that impacted device imaging, such as rendering the cornea opaque, and fixation issues that could hinder the ability to obtain high-quality images of either eye. Measured biometry data for both the Aladdin (▇▇▇▇▇▇▇

Subject Selection. This clinical trial can fulfill its objectives only if appropriate subjects are enrolled. The following eligibility criteria are designed to select subjects for whom protocol treatment is considered appropriate. All relevant medical and non-medical conditions should be taken into consideration when deciding whether this protocol is suitable for a particular subject.

Subject Selection. Indicate how many subjects will be included in the study, how they will be recruited, from where recruited, and when. When vulnerable populations are involved, describe why they are necessary. Provide criteria for the exclusion or inclusion of potential subjects, and justification for the exclusion of any groups on the basis of age, sex, ethnicity, or social or economic factors.